Company · CIK 1786205
Arcellx, Inc.
| CIK | 1786205 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | CA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2022-03-24 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-271731 | 2023-05-08 | 2023-05-08 | 1 | |
| 333-265573 | 2022-06-14 | 2022-06-16 | 5 | |
| 333-262191 | 2022-01-14 | 2022-02-07 | 4 |
Filings
12| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2023-05-08 | S-3ASRShelf registered | 333-271731 | 0001193125-23-138365 |
| 2022-06-16 | 424B4Final prospectus | 333-265573 | 0001193125-22-175611 |
| 2022-06-15 | EFFECTDeclared effective | 333-265573 | 9999999995-22-001836 |
| 2022-06-15 | S-1/AAmendment | 333-265573 | 0001193125-22-174521 |
| 2022-06-14 | S-1/AAmendment | 333-265573 | 0001193125-22-173887 |
| 2022-06-14 | S-1Registration filed | 333-265573 | 0001193125-22-173436 |
| 2022-06-13 | DRSDraft made public | 377-06226 | 0000950123-22-006854 |
| 2022-02-07 | 424B4Final prospectus | 333-262191 | 0001193125-22-029768 |
| 2022-02-03 | EFFECTDeclared effective | 333-262191 | 9999999995-22-000328 |
| 2022-01-31 | S-1/AAmendment | 333-262191 | 0001193125-22-022267 |
| 2022-01-14 | S-1Registration filed | 333-262191 | 0001193125-22-010026 |
| 2020-05-01 | DRSDraft made public | 377-03146 | 0000950123-20-003734 |